GlassScriptPhysician profile
Chandrika Joshi
NPI 1992797757
$2,663.98
in general payments reported to CMS, 2019-2025
32 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $56.81 · 2021: $391 · 2022: $431 · 2023: $810 · 2024: $258 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.18 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $313.05 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $169.14 | 2019-2022 | |
| Astellas Pharma US INC | $162.87 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $153.41 | 2019-2024 | Evenity, Prolia |
| Myovant Sciences INC. | $151.21 | 2021-2022 | |
| Hologic Sales and Service, LLC | $141.17 | 2021-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $129.16 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.16 | 2019-2023 | |
| Caldera Medical, INC | $95.06 | 2023 | Desara |
| Myriad Women'S Health, INC. | $80.57 | 2023 | Myrisk |
| Exact Sciences Corporation | $72.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $72.27 | 2022-2023 | |
| Aspira Women'S Health INC | $64.12 | 2022 | |
| Exeltis, USA INC. | $63.80 | 2021-2025 | Slynd |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $58.29 | 2019-2022 | |
| Coopersurgical, INC. | $46.53 | 2019-2025 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $36.55 | 2019 | |
| Channel Medsystems, INC. | $34.42 | 2023 | |
| Lupin INC. | $31.37 | 2019 | |
| Merck Sharp & Dohme LLC | $29.55 | 2019-2024 | Gardasil, Gardasil 9 |
| Avion Pharmaceuticals | $24.93 | 2019 | |
| Smith+Nephew, INC. | $21.49 | 2022 | |
| Boston Scientific Corporation | $21.12 | 2019 | |
| Sage Therapeutics, LLC | $20.90 | 2025 | Zurzuvae |
| Gynesonics, INC. | $17.72 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bard Access Systems, INC. | $17.20 | 2019 | |
| Covidien LP | $16.40 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.68 | 2023 | Exparel |
| Avation Medical, INC. | $13.95 | 2025 | Vivally System |
| Meditrina | $13.79 | 2023 | |
| Allergan, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandrika Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.